NIAID Chief Anthony Fauci to Step Down in December
After more than 50 years in government service, Fauci is stepping down as NIAID director and chief medical adviser to the president.
Dr. Anthony Fauci will be stepping down from his positions as chief medical adviser to President Joe Biden, director of the National Institute of Allergy and Infectious Disease (NIAID) and chief of the NIAID Laboratory of Immunoregulation this December, Fauci said Monday.
Fauci had previously said he would retire before the end of Biden’s term.
While Fauci served as NIAID director for 38 years, he was thrust into the national spotlight with the emergence of the COVID-19 pandemic in 2020. Under Fauci, NIAID’s pandemic response included organizing large-scale clinical trials called the COVID-19 Prevention Network (CoVPN) and new efforts to help researchers share infectious disease data and access biomedical resources.
Best known for his role as chief medical adviser to presidents Donald Trump and Joe Biden, he has advised seven U.S. presidents beginning with Ronald Reagan. Over the course of his career, he has played a pivotal role in responding to infectious disease threats such as HIV/AIDS, West Nile virus, the anthrax attacks, pandemic influenza, various bird influenzas and the Ebola and Zika viruses.
“Because of Dr. Fauci’s many contributions to public health, lives here in the United States and around the world have been saved,” Biden said in a written statement. “Whether you’ve met him personally or not, he has touched all Americans’ lives with his work.”
Although he is leaving NIAID, Fauci said he is not retiring from the health science field. After more than 50 years of government service, he plans to continue his work to advance science and public health, with the goal of inspiring and mentoring the next generation of scientific leaders.
“Thanks to the power of science and investments in research and innovation, the world has been able to fight deadly diseases and help save lives around the globe,” Fauci said. “I am proud to have been part of this important work and look forward to helping to continue to do so in the future.”
NIAID is expected to name an interim director before Fauci departs and to conduct a national search for his replacement.
This is a carousel with manually rotating slides. Use Next and Previous buttons to navigate or jump to a slide with the slide dots
-
From Fax Machines to AI: Health Agencies Accelerate Modernization
HRSA and CMS officials outlined plans to replace legacy transplant systems, automate prior authorization and expand AI-assisted care.
3m read -
Health IT Leaders Eye AI, Data Sharing to Improve Affordability
Healthy policy leaders say smarter data use, streamlined workflows and transparent AI tools could help lower costs and improve patient care.
3m read -
CMS Bets on Tech as US Healthcare Hits 'Inflection Point'
CMS leader Chris Klomp urges private sector innovation as new programs aim to accelerate tech-driven care for Medicare beneficiaries.
3m read -
How Tech Can Bridge Gaps in Rural Healthcare Data Struggles
Prescription price transparency and nationwide data sharing are among the areas in which officials say technology can reduce costs.
4m read
